In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Praxis Precision Medicines Inc’s stock clocked out at $37.64, up 1.18% from its previous closing price of $37.20. In other words, the price has increased by $1.18 from its previous closing price. On the day, 0.59 million shares were traded. PRAX stock price reached its highest trading level at $39.0 during the session, while it also had its lowest trading level at $35.765.
Ratios:
To gain a deeper understanding of PRAX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.77 and its Current Ratio is at 10.77. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 03, 2025, Reiterated its Buy rating but revised its target price to $105 from $120 previously.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $111.
On August 05, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $134.Oppenheimer initiated its Outperform rating on August 05, 2024, with a $134 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 14 ’24 when Nemiroff Alex sold 8,239 shares for $80.20 per share. The transaction valued at 660,827 led to the insider holds 10,301 shares of the business.
Mastrocola Lauren sold 5,188 shares of PRAX for $424,318 on Nov 14 ’24. The Principal Accounting Officer now owns 5,613 shares after completing the transaction at $81.78 per share. On Nov 14 ’24, another insider, Mastrocola Lauren, who serves as the Officer of the company, bought 5,189 shares for $81.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRAX now has a Market Capitalization of 758942848 and an Enterprise Value of 367746720. For the stock, the TTM Price-to-Sale (P/S) ratio is 88.77 while its Price-to-Book (P/B) ratio in mrq is 1.64. Its current Enterprise Value per Revenue stands at 42.996 whereas that against EBITDA is -1.841.
Stock Price History:
The Beta on a monthly basis for PRAX is 2.67, which has changed by -0.30502218 over the last 52 weeks, in comparison to a change of 0.09969199 over the same period for the S&P500. Over the past 52 weeks, PRAX has reached a high of $91.83, while it has fallen to a 52-week low of $26.70. The 50-Day Moving Average of the stock is -7.35%, while the 200-Day Moving Average is calculated to be -37.99%.
Shares Statistics:
It appears that PRAX traded 546.57K shares on average per day over the past three months and 427770 shares per day over the past ten days. A total of 19.42M shares are outstanding, with a floating share count of 18.74M. Insiders hold about 7.07% of the company’s shares, while institutions hold 105.48% stake in the company. Shares short for PRAX as of 1744675200 were 1847505 with a Short Ratio of 3.38, compared to 1741910400 on 2060595. Therefore, it implies a Short% of Shares Outstanding of 1847505 and a Short% of Float of 9.1800004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
